Compound ID | 1800
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Enterobacteriaceae and non-fermenter. Membrane-acting peptides |
| Description: | Synthetic peptide |
| Institute where first reported: | Lytica Therapeutics |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |